Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 24:45:100982.
doi: 10.1016/j.bbih.2025.100982. eCollection 2025 May.

Predictors of fatigue progression in long COVID among young people

Affiliations

Predictors of fatigue progression in long COVID among young people

Elias Myrstad Brodwall et al. Brain Behav Immun Health. .

Abstract

Long COVID, or post-COVID-19 condition (PCC), has emerged as a significant health concern, with fatigue being the most prevalent persistent symptom among young people. However, research on predictors of fatigue progression in young populations is limited. This study aimed to investigate factors during acute SARS-CoV-2 infection that could predict fatigue progression between six and 12 months post-infection in a cohort of young people with chronic fatigue following COVID-19. Data from the Long-Term Effects of COVID-19 in Adolescents (LoTECA) project were analyzed. A total of 93 participants (mean age 18.5 years, 84 % female) with chronic fatigue at six months, completed the 12-month follow-up. Multivariate analyses identified non-European ethnicity, higher interferon gamma (IFN-γ) levels, and lower RR-interval (higher resting heart rate) during acute infection as significant predictors of fatigue progression from six to 12 months. These three factors explained 21 % of the variance in the fatigue score, highlighting the importance of ethnicity, immune response, and autonomic function in the trajectory of long COVID fatigue. Early identification and targeted interventions, particularly for ethnic minorities and those with specific immune or autonomic markers during acute infection, may be helpful in reducing long-term fatigue. Further research is needed to explore treatment strategies for affected young populations.

Keywords: Adolescents; Chronic fatigue; Fatigue risk factors; Fatigue trajectory; Long COVID; Post-COVID condition (PCC); Post-infective fatigue syndrome (PIFS); SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Elias Brodwall reports financial support was provided by Dam Foundation. Vegard Bruun Bratholm Wyller reports financial support was provided by Research Council of Norway. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flowchart of LoTECA.

References

    1. Bakken I.J., Tveito K., Gunnes N., Ghaderi S., Stoltenberg C., Trogstad L., et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med. 2014;12:167. - PMC - PubMed
    1. Behnood S., Newlands F., O'Mahoney L., Haghighat Ghahfarokhi M., Muhid M.Z., Dudley J., et al. Persistent symptoms are associated with long term effects of COVID-19 among children and young people: results from a systematic review and meta-analysis of controlled studies. PLoS One. 2023;18(12) - PMC - PubMed
    1. Benedict R.H.B., Schretlen D., Groninger L., Brandt J. Hopkins verbal learning test – revised: normative data and analysis of inter-form and test-retest reliability. Clin. Neuropsychol. 1998;12(1):43–55.
    1. Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27(9):1607–1613. - PMC - PubMed
    1. Buonsenso D., Valentini P., De Rose C., Tredicine M., Pereyra Boza M.D., Camponeschi C., et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J. Clin. Med. 2022;11(15) [Internet] - PMC - PubMed

LinkOut - more resources